| Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) MF Marmor, U Kellner, TYY Lai, RB Melles, WF Mieler Ophthalmology 123 (6), 1386-1394, 2016 | 1729* | 2016 |
| EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic … A Koh, WK Lee, LJ Chen, SJ Chen, Y Hashad, H Kim, TY Lai, S Pilz, ... Retina 32 (8), 1453-1464, 2012 | 665 | 2012 |
| Pachychoroid disease CMG Cheung, WK Lee, H Koizumi, K Dansingani, TYY Lai, KB Freund Eye 33 (1), 14-33, 2019 | 549 | 2019 |
| Updates of pathologic myopia K Ohno-Matsui, TYY Lai, CC Lai, CMG Cheung Progress in retinal and eye research 52, 156-187, 2016 | 496 | 2016 |
| Aqueous humor levels of vascular endothelial growth factor and pigment epithelium–derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization JP Tong, WM Chan, DTL Liu, TYY Lai, KW Choy, CP Pang, DSC Lam American journal of ophthalmology 141 (3), 456-462, 2006 | 440 | 2006 |
| Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial WM Chan, TYY Lai, RYK Lai, DTL Liu, DSC Lam Ophthalmology 115 (10), 1756-1765, 2008 | 385 | 2008 |
| Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management CMG Cheung, TYY Lai, P Ruamviboonsuk, SJ Chen, Y Chen, KB Freund, ... Ophthalmology 125 (5), 708-724, 2018 | 349 | 2018 |
| Central serous chorioretinopathy: towards an evidence-based treatment guideline TJ Van Rijssen, EH Van Dijk, S Yzer, K Ohno-Matsui, JEE Keunen, ... Progress in retinal and eye research 73, 100770, 2019 | 347 | 2019 |
| Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series WM Chan, DSC Lam, TYY Lai, DTL Liu, KKW Li, Y Yao, TH Wong Ophthalmology 111 (8), 1576-1584, 2004 | 338 | 2004 |
| Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment AHC Koh, LJ Chen, SJ Chen, Y Chen, A Giridhar, T Iida, H Kim, TYY Lai, ... Retina 33 (4), 686-716, 2013 | 319 | 2013 |
| Choroidal neovascularization in pathological myopia K Neelam, CMG Cheung, K Ohno-Matsui, TYY Lai, TY Wong Progress in retinal and eye research 31 (5), 495-525, 2012 | 309 | 2012 |
| Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study WM Chan, TYY Lai, RYK Lai, EWH Tang, DTL Liu, DSC Lam Retina 28 (1), 85-93, 2008 | 301 | 2008 |
| Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial A Koh, TYY Lai, K Takahashi, TY Wong, LJ Chen, P Ruamviboonsuk, ... JAMA ophthalmology 135 (11), 1206-1213, 2017 | 290 | 2017 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 267 | 2022 |
| Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study TYY Lai, WM Chan, H Li, RYK Lai, DTL Liu, DSC Lam British Journal of Ophthalmology 90 (7), 869-874, 2006 | 250 | 2006 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 245 | 2022 |
| Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome AKH Kwok, WWY Li, CP Pang, TYY Lai, GHF Yam, NR Chan, DSC Lam American journal of ophthalmology 132 (2), 178-183, 2001 | 238 | 2001 |
| Epiretinal membrane surgery with or without internal limiting membrane peeling AKH Kwok, TYY Lai, KSC Yuen Clinical & experimental ophthalmology 33 (4), 379-385, 2005 | 236 | 2005 |
| Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic … WM Chan, TYY Lai, DTL Liu, DSC Lam American journal of ophthalmology 143 (6), 977-983. e1, 2007 | 209 | 2007 |
| The REVEAL study: ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema T Ishibashi, X Li, A Koh, TYY Lai, FL Lee, WK Lee, Z Ma, M Ohji, N Tan, ... Ophthalmology 122 (7), 1402-1415, 2015 | 206 | 2015 |
